| A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006) (NCT07348237) | Merck Sharp & Dohme LLC | 2026-03-02 |
| Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies (NCT07523555) | Beijing Biotech | 2026-03-02 |
| SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus (NCT07523542) | Beijing Biotech | 2026-03-02 |
| Catequentinib Hydrochloride (AL3818) Drug-Drug Interaction Study in Healthy Volunteers (NCT07438886) | Advenchen Laboratories Nanjing Ltd. | 2026-03-02 |
| Target-Selected CAR-NK Cells (CD30, CD5, or Mesothelin) for Relapsed/Refractory B2 Thymoma or Thymic Carcinoma (NCT07598955) | Beijing Biotech | 2026-03-02 |
| Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma (NCT07492628) | Beijing Biotech | 2026-03-02 |
| A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KL0011034 Injection in Healthy Volunteers (NCT07474545) | Hunan Kelun Pharmaceutical Co., Ltd. | 2026-03-02 |
| Dual-Target CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma (NCT07627711) | Beijing Biotech | 2026-03-02 |
| A Study of Olomorasib (LY3537982) in Healthy Participants (NCT07439250) | Eli Lilly and Company | 2026-03-02 |
| A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With or Without Comorbid Asthma (NCT07436949) | Bambusa Therapeutics | 2026-03-02 |
| Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) pt2 (NCT07617753) | Beijing Biotech | 2026-03-02 |
| Dual-Target CAR-NK Cells Targeting MSLN, EGFR, or HER2 in Advanced NSCLC (NCT07641023) | Beijing Biotech | 2026-03-02 |
| Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced Melanoma (NCT07627698) | Beijing Biotech | 2026-03-02 |
| Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma (NCT07502287) | Beijing Biotech | 2026-03-02 |
| Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC) (NCT07744256) | Beijing Biotech | 2026-03-02 |
| EGFR/HER2 Dual-Target CAR-NK Cells for Recurrent or Metastatic HNSCC (NCT07617805) | Beijing Biotech | 2026-03-02 |
| PRISM-NK: Precision-Matched Allogeneic Single- or Dual-Target CAR-NK Cells for Advanced Solid Tumors (NCT07510828) | Beijing Biotech | 2026-03-02 |
| A Clinical Study to Explore the Safety and Efficacy of CT1390B in Relapsed/ Refractory Acute Myeloid Leukemia (NCT07441980) | Institute of Hematology & Blood Diseases Hospital, China | 2026-03-02 |
| Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors (NCT07374848) | Zai Lab (Shanghai) Co., Ltd. | 2026-03-02 |
| Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234 (NCT07453602) | Arcutis Biotherapeutics, Inc. | 2026-03-02 |
| A Study to Evaluate ALN-4915 in Adult Healthy Volunteers (NCT07535606) | Alnylam Pharmaceuticals | 2026-03-02 |
| Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC (NCT07500220) | Beijing Biotech | 2026-03-02 |
| Fluorescence-Guided Imaging of Brain Tumors: A Safety Study Using SBK2-ICG (NCT07438860) | Tiffany Hodges | 2026-03-02 |
| Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions) (NCT07290244) | Life Biosciences Inc. | 2026-03-02 |
| An Efficacy and Safety Study of NTB003 in Participants With Thyroid Eye Disease (TED) (NCT07462130) | Nanjing Chia-tai Tianqing Pharmaceutical | 2026-03-01 |
| [Effects of Selected Statins on Cardiovascular Parameters in Healthy Volunteers] (NCT07389304) | Shaheed Benazir Bhutto University Sheringal Dir Upper | 2026-03-01 |
| Tadalafil 5 mg on Storage Lower Urinary Tract Symptoms After Anatomical Endoscopic Enucleation of the Prostate (NCT07466030) | Assiut University | 2026-03-01 |
| PIC1 Injection Therapy for Relapsed/Refractory B-NHL (NCT07456371) | Chongqing Precision Biotech Co., Ltd | 2026-03-01 |
| A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01 (NCT05570422) | Kortuc, Inc. | 2026-03-01 |
| Evaluating Safety, Tolerability, and Efficacy of Autologous MitoCell Transplantation in Subjects With Idiopathic Parkinson's Disease (NCT05094011) | Taiwan Mitochondrion Applied Technology Co., Ltd. | 2026-03-01 |
| Impact of Eradication Therapy on Helicobacter Pylori Infection With Chronic Obstructive Pulmonary Disease: (NCT07574879) | Zagazig University | 2026-03-01 |
| A Study of QLH2405 in Healthy Participants and Participants With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease (NCT07489599) | Qilu Pharmaceutical Co., Ltd. | 2026-03-01 |
| A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG) (NCT07455045) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2026-03-01 |
| Clinical Trial of TB511 in Advanced Solid Tumors (NCT06400160) | Twinpig Biolab, Inc. | 2026-03-01 |
| A Study to Assess CLBR001+SWI019 in Subjects With Autoimmune Diseases (NCT06913608) | Calibr, a division of Scripps Research | 2026-03-01 |
| Intraneural Administration of scAAV9/JeT-GAN Into the Vagus Nerve for Patients With Giant Axonal Neuropathy (GAN) (NCT07543991) | University of Texas Southwestern Medical Center | 2026-03-01 |
| Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis (NCT07477639) | Tr1X, Inc. | 2026-03-01 |
| Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HLX97 (a KAT6A/B Inhibitor) in Patients With Advanced/Metastatic Solid Tumor (NCT07480681) | Shanghai Henlius Biotech | 2026-03-01 |
| Prospective Management of Plaque Instability With Statins and Extra Folic Acid (NCT07680595) | Ruijin Hospital | 2026-03-01 |
| A Clinical Study of BioTTT001 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer (NCT06283134) | China Medical University, China | 2026-03-01 |
| Xenon Therapy for Children With Autism Spectrum Disorder (NCT07435103) | The Children's Hospital of Zhejiang University School of Medicine | 2026-03-01 |
| Sodium Aescinate for the Treatment of Low Back Pain (LBP) in Adults (NCT07339631) | Xijing Hospital | 2026-03-01 |
| Everolimus in CDK12-Deficient Metastatic Colorectal Cancer (EVER-RECODE) (NCT07435584) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-03-01 |
| Optimizing Accelerated TMS for Chronic Pain With Thompson Sampling (NCT07103135) | University of Minnesota | 2026-03-01 |
| A Proof-of-concept Trial to EvaluAte the efficaCy and Safety Of Cell Therapy TRX103 in Patients With Active, Non-infectious Uveitis (NCT07427628) | Quan Dong Nguyen | 2026-03-01 |
| Wayne State Warriors Marijuana Clinical Research Program: Cannabinoid Adjunct to Prolonged Exposure & Recovery (NCT06222268) | Wayne State University | 2026-03-01 |
| JSKN016HC in Patients With Advanced or Metastatic Solid Malignant Tumors (NCT07475559) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2026-03-01 |
| Bacteriophage Therapy for Staphylococcus Lugdunensis Prosthetic Joint Infection (NCT07461337) | University of Calgary | 2026-03-01 |
| A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of Gastrodin Injection in Healthy Chinese Subjects (NCT07422142) | Kunming Pharmaceuticals, Inc. | 2026-03-01 |
| A Study to Compare the PK , Safety, and Immunogenicity of QL2109 With Daratumumab in Male Subjects (NCT07400744) | Qilu Pharmaceutical Co., Ltd. | 2026-03-01 |
| Rimegepant Combined With AG Chemotherapy As First-Line Treatment For Metastatic Pancreatic Ductal Adenocarcinoma (NCT07475234) | Xiuchao Wang | 2026-03-01 |
| Safety and PK of Intrathecal CNTX-3001 for Intractable Chronic Low Back Pain (NCT07122453) | Centrexion Therapeutics | 2026-03-01 |
| Grouping Immune-modulation With Cryoablation (LOGIC) for Breast Cancers (NCT05806385) | Texas Tech University Health Sciences Center | 2026-03-01 |
| SNB-101 for Treatment of Extensive Stage Small Cell Lung Cancer (NCT07391813) | SN BioScience | 2026-03-01 |
| Personalized Antisense Oligonucleotide Therapy for A Single Patient With CHCHD10 ALS (nL18576) (NCT07423494) | n-Lorem Foundation | 2026-03-01 |
| Examining a Novel Gastrointestinal Intervention to Negate Environmental Toxicants (ENGINE) (NCT07226440) | University of California, San Francisco | 2026-03-01 |
| The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions in Adolescent Patients With Retinitis Pigmentosa (NCT02018692) | Sheba Medical Center | 2026-03-01 |
| CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus (NCT07432334) | Vinmec Research Institute of Stem Cell and Gene Technology | 2026-03-01 |
| YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases (NCT07439029) | Children's Hospital of Fudan University | 2026-03-01 |
| A Phase Ia Single Ascending-Dose Study of Subcutaneous EB070 Injection in Healthy Volunteers (NCT07413536) | Biotech Pharmaceutical Co., Ltd. | 2026-03-01 |
| PNEUMOSTEM® for Improving Respiratory Outcomes in Very Premature Infants Diagnosed With Early Pulmonary Arterial Hypertension (NCT07368088) | Samsung Medical Center | 2026-03-01 |
| A Phase I/II Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of the EMB-07 Combination Therapy in Patients With Aggressive B-Cell Non-Hodgkin Lymphoma (NCT07432022) | Shanghai EpimAb Biotherapeutics Co., Ltd. | 2026-03-01 |
| PIN in Combination With Sintilimab in Previously Treated pMMR/MSS CRC With Hepatic Metastases (NCT07411781) | Chinese PLA General Hospital | 2026-03-01 |
| First-in-Human Study of ISH0688: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics (NCT07505043) | SUNHO（China）BioPharmaceutical CO., Ltd. | 2026-03-01 |
| Hydrogen In Neonatal Encephalopathy (HIE) Trial (NCT07411911) | Boston Children's Hospital | 2026-03-01 |
| Effects of Selected Statins on Blood Glucose Levels in Healthy Volunteers (NCT07378293) | Shaheed Benazir Bhutto University Sheringal Dir Upper | 2026-03-01 |
| Phase I Split-Belt Treadmill Dosing for Subacute Stroke (NCT07469163) | University of Calgary | 2026-03-01 |
| Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population (NCT07401680) | University of Alberta | 2026-03-01 |
| Butyric Acid Supplementation for Gut Improvement After Cardiac Surgery in Kids (NCT06882772) | University of Nebraska | 2026-03-01 |
| Safety and Immunogenicity of PRO-169 in Patients With Diabetic Macular Edema (NCT07429474) | Laboratorios Sophia S.A de C.V. | 2026-03-01 |
| Enhancing Orthographic Communication and Literacy Outcomes for AAC Learners (NCT07384156) | Penn State University | 2026-03-01 |
| Glecirasib Combined With Ivonescimab for First-line Treatment of KRAS G12C-mutated NSCLC (NCT07339839) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-03-01 |
| KAN-004 for Immune-Related Diarrhea or Colitis (NCT07196410) | Centre hospitalier de l'Université de Montréal (CHUM) | 2026-03-01 |
| IBI363 Plus Bevacizumab With or Without Nab-Paclitaxel for Second-Line Treatment of Advanced Gastric Cancer (NCT07361991) | The First Affiliated Hospital of Zhengzhou University | 2026-03-01 |
| The Phase I Study of SIG001 Antibody on Cancer Therapy. (NCT07486700) | Peking University | 2026-03-01 |
| Lung Functional Avoidance Radiotherapy Using Hyperpolarized Xenon MRI (NCT07355231) | Xemed LLC | 2026-03-01 |
| Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma (NCT07183852) | Vastra Gotaland Region | 2026-03-01 |
| Prospective Single-Arm Safety Study of Cervical LVA in AD Patients (NCT07458620) | Chang Gung Memorial Hospital | 2026-03-01 |
| Monitoring Early Response to Targeted Therapy in Stage IV HER2+ Breast Cancer Patients With Advanced PET/MR Imaging (NCT04273555) | University of Alabama at Birmingham | 2026-03-01 |
| A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection (NCT03038802) | Vaxine Pty Ltd | 2026-03-01 |
| Pharmacokinetic Study of Buagafuran Capsules in Participants With Hepatic Impairment and Normal Hepatic Function (NCT07457190) | Beijing Union Pharmaceutical Factory Ltd | 2026-03-01 |
| A Study of BEBT-701 in Patients With Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Cholesterol（LDL-C） (NCT07368608) | BeBetter Med Inc | 2026-03-01 |
| A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Snow Mountain Virus (NCT07198139) | Cocrystal Pharma, Inc. | 2026-03-01 |
| Study on the Safety and Efficacy of Intratympanic Injection of Small Extracellular Vesicles Derived From Mesenchymal Stem Cells in Severe and Profound Sudden Sensorineural Hearing Loss (NCT07404709) | The Affiliated Hospital of Qingdao University | 2026-02-28 |
| A Phase 1 Comparative Study to Evaluate Pharmacokinetics, Immunogenicity, Safety and Tolerability of Bmab3000 and Herceptin Hylecta® After a Single 600 mg SC Injection in Healthy Male Volunteers (NCT07299955) | Biocon Biologics UK PLC | 2026-02-28 |
| Stereotactic Intracerebral Injection of Allogenic IPSC-DAPs in Patients With Parkinson's Disease (NCT07212088) | iCamuno Biotherapeutics Ltd. | 2026-02-28 |
| Lisatoclax Plus R-CHOP or Pola-R-CHP in Untreated DLBCL: A Phase Ib/II Study (NCT07398638) | Sun Yat-sen University | 2026-02-28 |
| SYS6090 Combination Therapy in Advanced Lung Cancer (NCT07472647) | Shanghai JMT-Bio Inc. | 2026-02-28 |
| To studyJUV-161 Administered to Healthy Volunteers Undergoing Unilateral Lower Limb Immobilization (ULLI) (NCT07397468) | Juvena Therapeutics | 2026-02-28 |
| CRISPR Delivered Anti-BCMA Car-T Therapy for Relapsed or Refractory Multiple Myeloma (NCT07340853) | Thomas Martin, MD | 2026-02-28 |
| IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors (NCT07441174) | InxMed (Shanghai) Co., Ltd. | 2026-02-28 |
| A Food Effect Study to Evaluate the Relative Bioavailability of Nalbuphine Extended-Release Tablets (NAL ER) in Healthy Participants (NCT07487740) | Trevi Therapeutics | 2026-02-27 |
| A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis (NCT07171983) | Bristol-Myers Squibb | 2026-02-27 |
| Study of the Safety and Usefulness of Liposomal Curcumin in Multiple Myeloma (NCT07456605) | University Health Network, Toronto | 2026-02-27 |
| To Evaluate the Safety and Tolerability of Study Drug as a Third-line and Beyond Therapy for Recurrent or Metastatic Gastric Cancer (NCT07364422) | Onconic Therapeutics Inc. | 2026-02-27 |
| A IB/II Phase Clinical Study on the Safety, Tolerability, and Efficacy of SHR-9839(sc) in Combination Anti-tumor Therapy in Patients With Solid Tumors (NCT07229638) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2026-02-27 |
| Trial of Oligometastasis SBRT With Immediate, Simulation-Free Treatment Delivery (OLIGO-SWIFT) (NCT07079098) | Case Comprehensive Cancer Center | 2026-02-27 |
| A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours) (NCT07306559) | Boehringer Ingelheim | 2026-02-27 |
| Phase I Study of [111In]-FPI-2107 in EGFR Mutation-positive NSCLC (NCT07500987) | AstraZeneca | 2026-02-27 |
| A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM) (NCT07409246) | AbbVie | 2026-02-27 |